|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,234.00 JPY | +1.36% |
|
+4.94% | +10.50% |
| Jan. 05 | Tranche Update on NEXON Co., Ltd.'s Equity Buyback Plan announced on November 11, 2025. | CI |
| Nov. 21 | NEXON Co., Ltd., Q3 2025 Earnings Call, Nov 11, 2025 |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.6 | 6.37 | 6.72 | 7.72 | 7.34 | |||||
Return on Total Capital | 11 | 7.37 | 7.78 | 9.04 | 8.62 | |||||
Return On Equity % | 8.21 | 14.44 | 11.67 | 8.01 | 14.06 | |||||
Return on Common Equity | 8.45 | 14.86 | 11.84 | 8.05 | 14.08 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 76.45 | 73.72 | 70.1 | 67.42 | 63.06 | |||||
SG&A Margin | 27.95 | 29.89 | 30.99 | 28.06 | 25.26 | |||||
EBITDA Margin % | 44.39 | 37.44 | 32.75 | 33.26 | 33.27 | |||||
EBITA Margin % | 41.46 | 34.35 | 30.83 | 31.23 | 31 | |||||
EBIT Margin % | 41.46 | 34.35 | 30.83 | 31.23 | 31 | |||||
Income From Continuing Operations Margin % | 18.94 | 41.2 | 28.27 | 16.79 | 30.53 | |||||
Net Income Margin % | 19.19 | 41.86 | 28.37 | 16.68 | 30.22 | |||||
Net Avail. For Common Margin % | 19.19 | 41.86 | 28.37 | 16.68 | 30.22 | |||||
Normalized Net Income Margin | 24.19 | 31.49 | 27.24 | 23.87 | 26.41 | |||||
Levered Free Cash Flow Margin | 29.74 | 16.07 | 24.34 | 15.75 | 10.25 | |||||
Unlevered Free Cash Flow Margin | 29.82 | 16.17 | 24.44 | 15.96 | 10.54 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.37 | 0.3 | 0.35 | 0.4 | 0.38 | |||||
Fixed Assets Turnover | 9.11 | 7.88 | 8.69 | 8.57 | 7.68 | |||||
Receivables Turnover (Average Receivables) | 11.82 | 14.25 | 14.73 | 12.39 | 7.05 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 9.98 | 11.13 | 7.72 | 7.71 | 6.99 | |||||
Quick Ratio | 9.43 | 10.36 | 7.24 | 7.1 | 6.41 | |||||
Operating Cash Flow to Current Liabilities | 2.37 | 1.99 | 1.57 | 1.44 | 0.94 | |||||
Days Sales Outstanding (Average Receivables) | 30.96 | 25.61 | 24.78 | 29.45 | 51.92 | |||||
Average Days Payable Outstanding | 48.85 | 50.66 | 41.51 | 41.06 | 35.51 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 2.3 | 1.81 | 2.69 | 3.28 | 3.88 | |||||
Total Debt / Total Capital | 2.25 | 1.78 | 2.62 | 3.17 | 3.74 | |||||
LT Debt/Equity | 1.64 | 1.45 | 2.22 | 2.66 | 3.19 | |||||
Long-Term Debt / Total Capital | 1.61 | 1.43 | 2.16 | 2.57 | 3.07 | |||||
Total Liabilities / Total Assets | 16.44 | 14.26 | 16.81 | 17.44 | 18 | |||||
EBIT / Interest Expense | 340.32 | 227.2 | 185.48 | 93.76 | 65.65 | |||||
EBITDA / Interest Expense | 364.34 | 247.6 | 196.99 | 99.85 | 70.46 | |||||
(EBITDA - Capex) / Interest Expense | 357.78 | 243.78 | 192.23 | 97.44 | 68.74 | |||||
Total Debt / EBITDA | 0.13 | 0.15 | 0.2 | 0.21 | 0.27 | |||||
Net Debt / EBITDA | -3.91 | -5.06 | -4.74 | -4.03 | -3.78 | |||||
Total Debt / (EBITDA - Capex) | 0.13 | 0.15 | 0.21 | 0.22 | 0.28 | |||||
Net Debt / (EBITDA - Capex) | -3.99 | -5.14 | -4.85 | -4.13 | -3.87 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 17.9 | -6.33 | 28.88 | 19.69 | 5.4 | |||||
Gross Profit, 1 Yr. Growth % | 18.55 | -9.68 | 22.53 | 15.12 | -1.42 | |||||
EBITDA, 1 Yr. Growth % | 15.31 | -21 | 12.73 | 21.55 | 5.45 | |||||
EBITA, 1 Yr. Growth % | 15.6 | -22.4 | 15.67 | 21.21 | 4.63 | |||||
EBIT, 1 Yr. Growth % | 15.6 | -22.4 | 15.67 | 21.21 | 4.63 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -51 | 103.76 | -11.56 | -28.91 | 91.63 | |||||
Net Income, 1 Yr. Growth % | -51.39 | 104.35 | -12.66 | -29.63 | 90.98 | |||||
Normalized Net Income, 1 Yr. Growth % | -17.63 | 21.93 | 11.47 | 4.88 | 16.63 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -51.66 | 104.45 | -10.07 | -27.66 | 95.66 | |||||
Accounts Receivable, 1 Yr. Growth % | -26.91 | -16.04 | 73.2 | 24.4 | 134.25 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 13.71 | 3.54 | 29.72 | 14.99 | 19.88 | |||||
Total Assets, 1 Yr. Growth % | 19.9 | 14.44 | 5.7 | 5.3 | 14.45 | |||||
Tangible Book Value, 1 Yr. Growth % | 18.08 | 18.81 | 3.64 | 3.23 | 12.6 | |||||
Common Equity, 1 Yr. Growth % | 14.5 | 17.86 | 2.57 | 4.44 | 13.7 | |||||
Cash From Operations, 1 Yr. Growth % | 30.96 | -23.03 | 22.88 | -1.1 | -21.56 | |||||
Capital Expenditures, 1 Yr. Growth % | 64.35 | -32.32 | 76.72 | 21.64 | 6.81 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 8.98 | -49.38 | 95.14 | -22.52 | -31.44 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 8.92 | -49.21 | 94.83 | -21.83 | -30.38 | |||||
Dividend Per Share, 1 Yr. Growth % | 100 | 50 | 33.33 | 0 | 125 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.47 | 5.09 | 9.87 | 24.2 | 12.32 | |||||
Gross Profit, 2 Yr. CAGR % | 6.86 | 3.48 | 5.2 | 18.77 | 6.53 | |||||
EBITDA, 2 Yr. CAGR % | 7 | -4.55 | -5.63 | 17.05 | 13.21 | |||||
EBITA, 2 Yr. CAGR % | 6.49 | -5.28 | -5.25 | 18.41 | 12.62 | |||||
EBIT, 2 Yr. CAGR % | 6.49 | -5.28 | -5.25 | 18.41 | 12.62 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -26.59 | -0.08 | 34.24 | -20.71 | 16.72 | |||||
Net Income, 2 Yr. CAGR % | -27.74 | -0.34 | 33.59 | -21.6 | 15.93 | |||||
Normalized Net Income, 2 Yr. CAGR % | -8.34 | 0.22 | 16.58 | 8.12 | 10.6 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -28.07 | -0.58 | 35.6 | -19.34 | 18.97 | |||||
Accounts Receivable, 2 Yr. CAGR % | -18.27 | -21.66 | 20.59 | 46.79 | 70.71 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 16.61 | 8.51 | 15.9 | 22.13 | 17.41 | |||||
Total Assets, 2 Yr. CAGR % | 15.17 | 17.14 | 9.98 | 5.5 | 9.78 | |||||
Tangible Book Value, 2 Yr. CAGR % | 14.28 | 18.45 | 10.97 | 3.43 | 7.81 | |||||
Common Equity, 2 Yr. CAGR % | 13.07 | 16.17 | 9.95 | 3.5 | 8.97 | |||||
Cash From Operations, 2 Yr. CAGR % | 7.98 | 0.4 | -2.75 | 10.24 | -11.92 | |||||
Capital Expenditures, 2 Yr. CAGR % | 17.96 | 5.46 | 9.36 | 46.61 | 13.98 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 8.95 | -25.73 | -0.61 | 22.96 | -27.12 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 9.06 | -25.62 | -0.53 | 23.41 | -26.23 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 73.21 | 41.42 | 15.47 | 50 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.64 | 2.65 | 12.48 | 13.05 | 17.59 | |||||
Gross Profit, 3 Yr. CAGR % | 7.91 | 1.04 | 9.48 | 8.41 | 11.62 | |||||
EBITDA, 3 Yr. CAGR % | 6.12 | -3.29 | 0.89 | 2.68 | 13.05 | |||||
EBITA, 3 Yr. CAGR % | 5.65 | -4.17 | 1.24 | 2.85 | 13.63 | |||||
EBIT, 3 Yr. CAGR % | 5.65 | -4.17 | 1.24 | 2.85 | 13.63 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -0.61 | 3.16 | -4.06 | 8.61 | 6.41 | |||||
Net Income, 3 Yr. CAGR % | -0.31 | 2.19 | -4.63 | 7.89 | 5.48 | |||||
Normalized Net Income, 3 Yr. CAGR % | 11.18 | 0.8 | 3.83 | 12.54 | 10.89 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -0.83 | 1.89 | -3.85 | 9.98 | 8.38 | |||||
Accounts Receivable, 3 Yr. CAGR % | -15.95 | -17.54 | 2.05 | 21.85 | 71.54 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.82 | 12.08 | 15.16 | 15.59 | 21.38 | |||||
Total Assets, 3 Yr. CAGR % | 16.45 | 14.92 | 13.19 | 8.4 | 8.4 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.08 | 15.77 | 13.29 | 8.32 | 6.4 | |||||
Common Equity, 3 Yr. CAGR % | 15.13 | 14.64 | 11.45 | 8.08 | 6.79 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.46 | -3.54 | 7.39 | -2.2 | -1.58 | |||||
Capital Expenditures, 3 Yr. CAGR % | 4.49 | -1.98 | 25.27 | 13.31 | 31.92 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.24 | -15.62 | 2.49 | -8.53 | 1.21 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 15.31 | -15.47 | 2.53 | -8.21 | 1.97 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | 58.74 | 25.99 | 44.22 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.02 | 8.43 | 8.53 | 10.78 | 12.42 | |||||
Gross Profit, 5 Yr. CAGR % | 9.77 | 8.43 | 6.82 | 7.79 | 8.29 | |||||
EBITDA, 5 Yr. CAGR % | 9.95 | 6.24 | 1.25 | 4.39 | 5.65 | |||||
EBITA, 5 Yr. CAGR % | 12.34 | 6.28 | 1.15 | 4.29 | 5.65 | |||||
EBIT, 5 Yr. CAGR % | 12.34 | 6.28 | 1.15 | 4.29 | 5.65 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -0.04 | 40.68 | 12.09 | -7.14 | 3.76 | |||||
Net Income, 5 Yr. CAGR % | 0.39 | 41.67 | 12.07 | -8.09 | 3.12 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.25 | 12.9 | 13.31 | 3.67 | 6.49 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -0.14 | 41.01 | 12.39 | -7.2 | 4.7 | |||||
Accounts Receivable, 5 Yr. CAGR % | -8.9 | -8.25 | -2.89 | 3.86 | 25.37 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.21 | 11.68 | 10.98 | 16 | 16.06 | |||||
Total Assets, 5 Yr. CAGR % | 15.16 | 17.43 | 13.82 | 11.06 | 11.81 | |||||
Tangible Book Value, 5 Yr. CAGR % | 14.64 | 17.5 | 13.42 | 10.67 | 11.07 | |||||
Common Equity, 5 Yr. CAGR % | 13.65 | 17.54 | 13.03 | 10.05 | 10.45 | |||||
Cash From Operations, 5 Yr. CAGR % | 18 | 7.64 | 10.02 | 1.75 | -0.79 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.04 | -8.47 | 6.41 | 15.15 | 20.62 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 16.23 | -0.28 | 8.62 | -1.9 | -10.58 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.17 | -0.17 | 8.69 | -1.66 | -10.12 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0 | 24.57 | - | - | 55.18 |
- Stock Market
- Equities
- 3659 Stock
- Financials NEXON Co., Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















